Post-operative pain treatment following total knee replacement surgery using BioWavePENS
T. Wanich, J. Gelber, R. Windsor, S. Rodeo. A randomized controlled pilot study to determine average maximum intensity settings, safety, and initial efficacy in terms of pain reduction, increased range of motion, and reduced pain medications, for a percutaneous neuromodulation pain therapy device (“BioWavePENS®”) following post-operative treatments for total knee replacement procedures.
Eastern Orthopaedic Association 39th Annual Meeting, October 22-25, 2008, Ritz-Carlton, Lake Las Vegas, Henderson, Nevada
American Academy of Orthopaedic Surgeons 2009 Annual Meeting, February 25-28, 2009, Las Vegas, Nevada
Treatment of chronic pain from osteoarthritis of the knee using BioWavePENS
Brian J. Cole, MD, MBA; Richard Kang, MD, MS; Paul B. Lewis, MD, MS; Adam Kramer, ATC; Jennifer K. Hayden, RN, MSN; Randomized Single-blinded Controlled Clinical Trial of a BiowavePENS device (Percutaneous Electrical Nerve Stimulation) versus Sham PENS treatment for the Osteoarthritic Knee. Orthopedics, June 2007, Volume 30, Number 6.
Treatment of pain from acute sports injuries using BioWavePRO
S. Panchal, J. Pergolizzi. White Paper on use of a neuromodulation pain therapy device (“BioWavePRO”) to treat acute sports injuries on New York Giants football players. 600 treatments on 80 players from June 2003 – December 2005. Unpublished manuscript, 2006.
Treatment of joint pain using BioWaveHOME
W. Coren. A clinical study of the efficacy of the BioWave home device for reducing pain and increasing range of motion over 24 hours following a 20-minute treatment of shoulder, knee, hip, and extremity pain. Unpublished manuscript, 2003.
Evaluation of optimal signal frequency and efficacy of BioWave
S. Diwan, H.C. Hemmings, R.F. Eliazo, S. Panchal. Symptomatic treatment of chronic low back pain: determination of optimal signal frequency and preliminary efficacy of a targeted noninvasive electronic pain control device. Anesth. Analg. Abstracts 96 S-1-S: 293, 2003.
Randomized, Double-Blinded, Comparative Crossover Trial Comparing Biowave vs TENS
S. Diwan MD, H. Hemmings MD, PhD, S. Panchal MD, Summary of a Randomized, Double-Blinded, Comparative Crossover Trial of the Safety and Efficacy of a Non-Invasive Targeted Electronic Pain Control Device (“Biowave System”) Versus Transcutaneous Electrical Nerve Stimulation (TENS) for the Symptomatic Treatment of Chronic Low Back Pain; March 2006.
Neuromodulation Pain Therapy Treatment
R. Yacoub. Neuromodulation pain therapy. ADVANCE for Physical Therapy and Rehab Medicine 23(13): 22-24, 2012.
"Since trying the BioWave machine, I have had immediate relief from the pain and have experienced about a 90 to 95% reduction in the pain. I have stopped taking medications and am feeling much better. The pain improvement is nothing short of miraculous."
George R. Dean
San Ramon, CA
"The BioWave is a life saver in pain reduction. I often experience sharp pangs, limping and generally incredible amounts of pain after engaging in strenuous weight bearing activity. Being an active person who does not wish to give up my hobbies over knee pain, I tried so many things to find a solution, and it wasn’t until I was introduced to the BioWave that I noticed a difference."
Managing Director, Drexion Investments
New York, NY
"I’m Nathan Stupar and am currently a linebacker for the New York Giants. I recently tore my ACL on punt coverage during our game against the Detroit Lions. During my recovery, I used BioWave nonstop. It blocked the pain, allowed me to complete my rehab more easily and helped me get back onto the field quicker. I began to play my best football on special teams. The BioWave gave me a quicker healing timeline and took away the pains. I highly recommend it to those who are looking for an edge on recovery and pain relief. It really does wonders. Thank you BioWave for keeping me right and to bringing me back as soon as possible so I can be back to playing on Sundays!"
Nathan Stupar Linebacker New York Giants
New York Giants Linebacker #57